Psychedelic treatment for PTSD faces misconduct hurdle

Short Wave

NPR

Daily News, Nature, Life Sciences, Astronomy, Science, News

4.7 • 6K Ratings

🗓️ 3 June 2024

⏱️ 17 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

People with post-traumatic stress disorder (PTSD) may soon have a new treatment option: MDMA, the chemical found in ecstasy. In August, the Food and Drug Administration plans to decide whether MDMA-assisted therapy for PTSD will be approved for market based on years of research. But serious allegations of research misconduct may derail the approval timeline.

NPR science reporter Will Stone talks to host Emily Kwong about the clinical trials on MDMA-assisted therapy research and a recent report questioning the validity of the results.

Read Will's full story here.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Transcript

Click on a timestamp to play from that location

0:00.0	Support for this podcast and the following message come from PWC,
0:04.3	pairing the right tech with the right solutions to help you gain a competitive edge.
0:08.6	Re-imagine operations, fuel innovation, and detect risks,
0:12.4	human lead, and tech-powered.
0:14.4	It's all part of the new equation from PWC.
0:17.4	You're listening to Shortwave
0:20.0	from NPR.
0:22.4	Hey Shortwavers, Emily Kwong here with... from NPR.
0:23.0	Hey Short Waivers, Emily Kwong here with NPR Science reporter Will Stone, who's been reporting on the use of
0:28.2	psychedelics for therapy.
0:30.3	And just a heads up, we do mention suicide and suicidal thoughts in this story.
0:34.4	Well, welcome. Let's get into this reporting. What do you got?
0:38.8	Hey Emily, I'm here to talk about MDMA. That's the chemical found in ecstasies, sometimes called
0:44.4	Molly. Researchers have been studying MDMA as a potential therapy for post-traumatic
0:50.0	stress disorder, PTSD. And in August the FDA is expected to decide whether it can be
0:56.0	used as a treatment option outside of clinical research meaning it would be
1:00.3	available to many more people. This would be a big development.
1:04.0	It would.
1:05.0	FDA approval would be actually an enormous milestone for the movement to bring
1:09.4	psychedelics into the mainstream of mental health care.
1:13.0	Wow.
1:14.0	But recent allegations have sparked controversy
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.